Ticlopidine and aspirin therapy following implantation of coronary artery stents

Annals of Pharmacotherapy

Volumn 31, Issue 6, 1997, Pages 770-772

  Hobson, Angela G ^a   Sowinski, Kevin M ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE; WARFARIN;

CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SURGERY; HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CLINICAL TRIALS; CORONARY DISEASE; CORONARY THROMBOSIS; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; STENTS; TICLOPIDINE;

EID: 0030965897     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Pepine CJ, Holmes DR Jr, Block PC, Mullins CE, Brinker JA, Nissen SE, et al. Coronary artery stents. J Am Coll Cardiol 1996;28:782-94.
2. Serruys PW, Di Mario C. Who was thrombogenic: the stent or the doctor? Circulation 1995;91:1891-3.
3. Schatz RA, Bairn DS, Leon M, Ellis SG, Goldberg S, Hirshfeld JW, et al. Clinical experience with the Palmaz-Schatz coronary stent. Circulation 1991;83:148-61.
4. Serruys PW, De Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
5. Eeckhout E, Kappenberger L, Goy J. Stents for intracoronary placement: current status and future directions. J Am Coll Cardiol 1996;27:757-65.
6. Flores-Runk P, Raasch RH. Ticlopidine and antiplatelet therapy. Ann Pharmacother 1993;27:1090-8.
7. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-9.
8. Schror K. Antiplatelet drugs. Drugs 1995;50:7-28.
9. De Caterina R, Sicari R, Bernini W, Lazzerini G, Strata GB, Giannessi D. Benefit/risk profile of combined antiplatelet therapy with ticlopidine and aspirin. Thromb Haemostas 1991;65:504-10.
10. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
11. Lablanche J-M, McFaddenm EP, Bonnet J-L, Grollier G, Danchin N, Bedossa M, et al. Combined antiplatelet therapy with ticlopidine and aspirin. Eur Heart J 1996;17:1373-80.
12. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, et al. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-22.
13. Goods CM, Al-Shaibi KF, Liu MW, Yadav JS, Jain SP, Dean LS, et al. Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting. Am J Cardiol 1996;78:1042-4.
14. Serruys PW, Emanuelsson H, Giessen W, Lunn AC, Kiemeney F, Macaya C, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Circulation 1996;93:412-22.
15. Schömig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
16. Popma JJ, Coller BS, Ohman EM, Bittl JA, Weitz J, Kuntz RE, et al. Antithrombotic therapy in patients undergoing coronary angioplasty. Chest 1995;108(4 suppl):486s-501s.